Wells Fargo maintains Underweight on WR Berkley, raises target to $68

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Wells Fargo analyst Elyse Greenspan maintained an Underweight rating on WR Berkley and raised the price target to $68 from $67, indicating a revised valuation outlook. This contrasts with Truist Securities' Buy rating and higher price target of $83.

powered bylight_fuzz_icon
46191954

*this image is generated using AI for illustrative purposes only.

Wells Fargo analyst Elyse Greenspan maintained an Underweight rating on WR Berkley (NYSE: WRB) while raising the price target to $68 from $67. The adjustment reflects a revised valuation outlook despite the cautious stance on the insurance holding company's performance potential.

Rating and Price Target

The research note updates the investment thesis on WR Berkley, retaining the Underweight recommendation. The price target increase of $1 suggests a modest upside potential based on the firm's analysis.

Metric Value
Rating Underweight
Previous Price Target $67
New Price Target $68

The revised target provides investors with a new benchmark for the stock's performance expectations. This update follows a previous rating from Truist Securities analyst Mark Hughes, who maintained a Buy rating with a price target of $83.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific valuation metrics drove the $1 price target increase despite the maintained Underweight rating?

How might WR Berkley's upcoming earnings report influence other analysts to align with either Wells Fargo's cautious stance or Truist's more bullish outlook?

What market conditions or sector trends could prompt Wells Fargo to upgrade the stock from Underweight in the future?

like17
dislike

WR Berkley Q2 adjusted EPS $1.27 beats estimates

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

WR Berkley reported Q2 adjusted EPS of $1.27, beating estimates by 16.51%, with sales rising 1.25% to $3.716 billion. Net income increased 12.7% to $452.3 million, driven by record premiums and investment income.

powered bylight_fuzz_icon
45178605

*this image is generated using AI for illustrative purposes only.

WR Berkley reported adjusted earnings per share of $1.27 for the second quarter of 2026, beating the analyst consensus estimate of $1.08 by 16.51%. This represents a 20.95% increase over earnings of $1.05 per share from the same period last year. The company reported quarterly sales of $3.716 billion, which missed the analyst consensus estimate of $3.759 billion by 1.14%. Sales increased 1.25% compared to $3.670 billion in the prior year.

The company’s performance was driven by disciplined underwriting and favorable pricing, contributing to record gross premiums written of $4.1 billion. Net income increased 12.7% to $452.3 million, or $1.15 per diluted share, compared to $401.3 million, or $1.00 per share, in the prior year. Operating income grew 18.2% to $497.1 million, reflecting an annualized operating return on beginning-of-year stockholders’ equity of 20.5%.

Second Quarter Financial Highlights

Metric Q2 2026 Q2 2025
Gross premiums written $4,144,000 $3,977,769
Net premiums written $3,430,234 $3,351,439
Net income $452,261 $401,288
Net income per diluted share $1.15 $1.00
Net investment income $418,714 $379,303
Operating income $497,145 $420,486
Return on equity 18.6% 19.1%
Operating return on equity 20.5% 20.0%

The Insurance segment grew gross and net premiums written by 5.4% and 3.7%, respectively, to record levels. Net investment income increased 10.4% to a record $418.7 million, supported by growth in invested assets and a higher portfolio yield. Pre-tax underwriting income grew 21.8% to $317.5 million. WR Berkley returned $334.1 million in capital to shareholders during the quarter, consisting of $185.5 million of special dividends, $111.5 million of share repurchases and $37.1 million of regular dividends.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Can WR Berkley sustain its current favorable pricing environment amidst potential market softening?

How will the company allocate capital between share repurchases and dividends given the strong capital returns?

What impact will rising interest rates have on future net investment income and portfolio yields?

like18
dislike

More News on WR Berkley Corp